Recall: D-0576-2018

Class II - Potentially Harmful

Class IIClassification
2018-02-20Initiated
TerminatedStatus
Hospira Inc. A Pfizer CompanyFirm

Product

Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a) Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-20; and b) NOVAPLUS, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-25.

Reason

Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.

Distribution

Nationwide in the USA and Puerto Rico.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.